1.2.
1.2.1.




B.3





.
2.1.







2.2.

2.2.2.
2.2.4.
(1)


12
2PC
No8

PC





Twitter






60
PC
MSKIN

firefox
→
10

LED

19
70



11
PC

12


50



2/3





30
8

126 59
(2)
N=126

20 0 2 1 3 2.4%
20 1 2 0 3 2.4%
30 11 10 0 21 16.8%
40 11 19 0 30 24.0%
50 8 24 0 32 25.6%
60 4 11 0 15 12.0%
70 1 16 0 17 13.6%
80 2 2 0 4 3.2%
38 86 1 125 100.0%
.
(2020304050607080)
3 2 20 19 24 11 12 3 94
0 1 1 9 8 4 5 1 29
0 0 0 1 0 0 0 0 1
0 0 0 1 0 0 0 0 1
3 3 21 30 32 15 17 4 125
.
109
N=119 63 30 22 2 2
N=104 30 33 24 4 13
N=109 42 28 23 3 13
N=95 30 24 22 5 14
N=109 46 36 21 2 4
N=107 54 26 21 1 5
N=75 36 11 9 1 18
19
.
5.41
N=126
80 ()30
40 2017()()()()12()
50 A10-01
40 A10-02
30 A10-03
50 A10-04
70 A10-05
80 A10-06
30 A10-07
40 A10-08
60 A10-09
60


30 …
30 231

50
3
23
70 MRI3
(3)(3
60 2859()2()
1


24H

70
()…
50

60 50()
()()
40 MRI
70 ()


30 (()
70 (()) 3(TV)231
(
50 1853


9mm
50
70

60
(


23
70 503()3
50 A10-10
40 A10-11




(
50 20
→
50 68 3110/9
70
60 4
60
40 15
70 38 33(
5557…62
3
531124
40 6
(

20 14(2015.10)(2018.6)
2019.4(

HDHD

50





70 59
(63)
(20148)3
40




0102__1)

2TV
30 1()()14
30
50
5



30

30 PC20182020LED
40 ()
()

60 Window98EXCEL

50
50 →→→→→
40






23CRPS



2
4
6
1

5
40
50 5
20
2
20

30 10-13

18 14%
98 78%
10 8%
126 100%
N=196

0
9


3638
50
30 6
50
70
30
40
60
60
30
40
30

60
(
30 ()
80
70
50
60 (
40 ()(
70
30

60
70 12


1
2


50

70 1
50 ()
40
40

20
70
70
40
70
50
70

30
40
30
30
40
60
40
30
39
×A-Q6×N=115
(N=13) (N=95) (N=6)
5 15 2
4 25 1
4 55 3
×A-Q6×N=88
(N=13) (N=71) (N=3)
4 18 2
5 28 0
4 25 1
40
×A-Q6×N=94
(N=16) (N=68) (N=9)
8 31 3
3 20 5
5 17 1
×A-Q6×N=77
(N=10) (N=62) (N=4)
7 14 1
2 20 2
1 28 1
×A-Q6×N=103
(N=15) (N=82) (N=5)
1 20 0
5 28 3
9 34 2
41
(N=15) (N=82) (N=4)
2 18 1
5 20 1
8 44 2
.
LED
N=995

97
41
N=211

1
1
1
1
1
1
1
23
23

4345
40 PC
30


80 3060
30
40 ()
40
50
60 34
30
()Dr.
()()
40
50
60
50


50
50
40
20
40
70 103

30
30

40 ()
50

45
.
N=126

39 14 0
26 1 1
24 12 0
5 2 0

1
1
1
1
1
1
2
1
2
2
2
LED 2
4
5
5
5
6
7
8

32
21
20
4851
30
50
80
30
40 LEDNHK
40
80
60
30
70 (1/3)…

60
40 ()()
50
70


50 ()
50
50 2
50
70
70 (
40

2
30
30
40
60

50
40
10()
40
30 10LUXLED
40 PC0PC22302
40
40 LEDLEDTVE-INKE-INKMP3DVD
40 12
30
60
40
50 TV
30
50 LED
40 1
50
()
30

1
1
1
1
1
() 2
3

9
5355
50
50
40 (PM8)(PM11)
50
30
60
40
30
50


80
50
60

50
60


50
…
70
60

70
70 …
30
50 LED
40 ()
(
40 LED
60
50
30

1
1
1
2

40
37
35
W 8
LED 11
10
50
50
70
30 ()
40
30 "
40 "
50 "
70
30 "
70
50 "
60
40
70 "
60
70
50
50
50
50 "
50 OK"
50 "
50 "(
40 (
20
50 ()
70 (…"
50
30
50 "
40 "LED
30
30 "
40 1

50
70 "
20

N=126

1
1
1
1
1
1
1
1
1
1
2

35
14
50
50 2030
30
50
30
60
60
30
40
30
70
60


70
70 ()
60
60
70

()
50
50
50
40
40
20 APD()
40 (
400
30
50
40



40
60
20
30 E-inkLED
40

50 PC
60
40
50
50 2
40
50
50 TEL

60
(
70
.
N=126
63

1
2
2
3
4
5

6
14

50
50 10151520
40 TV8TV10
30 ()399.9%
80 ipadFB
30
40
60 LINE11
30
40
80
50


70 10()

60 ()10
40

30
70 TV
60





50
50
50 2
CD
40
60
40
70

40
40


15
40 PC
30
40
60
50
50
30

20 2
40 TVTV
40
30 BOOX NOVA2E-inkLED
40
50
40
40 E-INK51015
40
40
30
60
40 (PC-Talker
50 PC
40 10Eizo
50
40
50
50
60
68(2
70
30
10.


40 ()
50 DVD
40 130
30
50

80
40 HDA4A3
60 10
60
30 ()
40




80

()
60


50
70
60


70



60 1
40
50
50



1
70
60
60
…


50
20
70
40


30
50



30
60
50





30
20
40
40
30 LED
40
50
40 ZOOM
40 LEDLEDLED
40
40
30
50
60
40
30
50
30 1
40 LED
50 30.50.2
40
50
50
60

70 JR
30
75
11.
34.914.3
11N=126

1
1
1
1
1
15
9
7779
40
40
50
70 5
80
40
60
30 …
40

30
50
60
70
30
60
50


50
50

70 1
60 2
50


1

70
30
40
40
30
30
50
30
50
60
40
40
40
40
40 LED
40 71
30
50
40
50
40
40
50 2
70
80

1
1
1
2
LED 2
2
2
4
5
9
0
0
2
0
10
40
40 PHS
60
30
50
30

40
50
50 10
40
1

30

20
60 ()
20
40
40
30 LED
40 PCPCWEB
40
40 PC1PTA
50
82
13.


1
1
1
1
2
3
3
0

40
40
30 B
50
50 12
60
49
50
50
40
40
40
30
40
50
30
50
60
30 1
40
40 600LED
40
40
50
40
50
50
60 ()(
14.

27
35
56
39
3
14


49
39
38
25
22
16
13
12
11
10

50
30
50
70 65
605
60
40
80 11
30
50

70
40 3
70
70
30
60

50
50

50
40
70
40
40
40



30 1
50
40
40
70
40
50
40
50
60
20
40
40
30
50
40
40
40
30
50
40
30
30 2
40
50 16
40 2
50

30
89
16.
16N=126
1
5
90
70
30
80
50
70
60
60
40

50 …
40
40


50
40
30
30
40
40
40
30
50
40
30
40 1.0
50 Dr.
60
70 1
30
91
17.
17N=126
5.6%14.3%78.6%1.6%
17N=99
5582214
1
5
4

40
30
40
60 ()2330451
30 (

60 (





40


50
40
40
30
40
40

50
50 16
40 3
50

60
70 65
94
60
52
44
13
42
95103
80
30
40 B18-04
60

40












3
40

70





60
50



40 B18-05
40


50
60
50







20
1

70
40








31


30
30
40
50
40
40
30
30
60 ()

BTX()

BTX34
40
40
30
40 LED225
40
60
40 2000
50
40 45LED
40
50
50

1

30

57
14
23
35
18
31
6
20 1
13

50 CT8080
50 B19-01
30 B19-02
50 B19-03
70
80
40 B19-04
60


40

1

70






…

50



(
()

70
70
30
50
60



40 B19-05


50 2115
40




50

50
…

70
50


50 (
70
60
2
40







91()

40
30
40
60
50
40
70
40
50
30
()

40
30 1.2.3.4.5.6.7.PoNS
50
40 TMS
40 5LED
30
50 PMDA
60
40 10
30
40 LEDLED
50 HD-Glass
40
50
50





60 ()

70 51065
30

115
()
N=125 6 19 67 29 4
N=125 5 29 62 24 5
N=125 8 33 56 24 4
N=125 27 57 26 11 4
N=125 30 45 32 12 6
N=125 20 42 44 13 6
N=125 16 44 45 15 5
N=125 25 46 34 16 4
116
51.7*62.46N=186,±15.36
LVADL
the low-vision-specific function and activities of daily living measureLVFAM
12 2 3 4 5 6 1 7 2
1 23 45 67
20 186
153276364951328
781071
0 3
12 0
19 1
24 1
27 1
30 1
33 3
36 2
38 3
40 9
42 10
44 8
46 8
48 5
50 7
51.6(N=118)
52 7
54 8
56 4
58 11
61 1
62.46(N=186)
63 3
65 5
68 3
71 2
75 1
80 2
88 3
100 5


1.2.3.4.5.6.7.8.9.
2.0 2.0 2.0 1.5 0.5 0.5 1.0 1.0 1.0
2.2 2.1 2.0 1.9 1.3 1.7 1.7 1.8 1.3
2.0 2.0 2.1 2.0 1.4 1.4 1.7 1.7 1.6
2.0 1.9 1.8 1.7 1.0 1.0 1.2 1.3 1.2

1.2.3.4.5.6.7.8.9.
2.4 2.3 2.2 2.2 1.6 1.6 1.8 1.9 1.9
2.0 1.9 1.9 1.8 1.3 1.4 1.6 1.7 1.6
1.9 1.8 1.7 1.4 0.6 0.9 1.1 1.3 0.9
1.3 1.2 1.1 1.1 0.7 0.3 0.4 0.5 0.3
120

1.2.3.4.5.6.7.8.9.
2.1 2.2 2.1 2.1 1.3 1.5 1.7 1.6 1.5
2.0 1.9 1.8 1.7 1.1 1.2 1.3 1.5 1.3
121
59 100.0%

53
28


12.3% 13.6%
15.5% 16.1%
15.9% 18.6%


0 1


50
50
30
30
80
30
60
70

70
TV
50
30
50

70
50
70


40
30
201844
201811 40
30
46
23
26
27
N=274
28
28
26
39
23
27
40
17
31
15
129
40
50
30
60
LED 30
70
50
60
1 70
1 50
70
40
70
40
() 30
10 40
130

9

40
60

() 40
50
50
20
40
2 30
131
.
N=59
40
60
30
50
40
60
30
50
20
40



132
.
N=59

21 2
2

60
30
60
TV()TV2 40
20
24(24) 40
133
.
4

30
30
30
60
TV 30
TV 50


1 40
50
50
50

() 20
40
123
40
2
134
.
4

30
40
50
60

50
70
20
40
70
3 30

135136
11
7
10
10830 40
30
30
30
60
30
()
60
40
1 60
30
50
50
70

40


40


13
12
2
10

40
30
60
50
70



235


138139
10.
10

40
30
40
60
30
1 70
2 70
40
1
20
1520 40
6() 70

30

1210 40



140
11.
9
9

2 40
40
30
60
LED(() 40
50
1 50
20
40


30
1346

40

30
142143
12

40
70
30
() 60
30
50
50
40

50
Dr.
20
Dr. 20
40

30

40

144
3..
72
7
5
3
2
2
1
1
1



44
23
6
3
1
1
2
1
1
1
1
1
1
1
1






2
1
7.5%

78
1
1
HD 1
1

9
2
3

41
41
10
1
1
1
1

51
2
1

18
1

1

2
1
1
1
1
1

1
WG
151


[footnoteRef:1] [1: Cerebellar Ataxia With Extreme Photophobia Associated With Anti-SOX1 Antibodies. Alessandro L, Schachter D, Farez MF, Varela F. Neurohospitalist. 2019 Jul;9(3):165-168. doi: 10.1177/1941874418802130. Epub 2018 Sep 24.PMID: 31244974 ]
Alessandro15
100040
IPRGCIPRGC





[footnoteRef:7]TBI[footnoteRef:8][footnoteRef:9]mildTBI [7: ( ), , 1 Page119-123(2007.10)] [8: Photophobia in neurologic disorders. Wu Y, Hallett M. Transl Neurodegener. 2017 Sep 20;6:26. doi: 10.1186/s40035-017-0095-3. eCollection 2017.PMID: 28932391] [9: Observer-perceived light aversion behaviour in photophobic subjects with traumatic brain injury. Yuhas PT, Shorter PD, McDaniel CE, Earley MJ, Hartwick AT. Clin Exp Optom. 2019 Nov;102(6):621-626. doi: 10.1111/cxo.12896. Epub 2019 Apr 29.PMID: 31037766]
Goodrich[footnoteRef:10])100TBIPTSDPTSDTBI383182PTSDTBI13/48,27% [10: Visual function, traumatic brain injury, and posttraumatic stress disorder. Goodrich GL, Martinsen GL, Flyg HM, Kirby J, Garvert DW, Tyler CW. J Rehabil Res Dev. 2014;51(4):547-58. doi: 10.1682/JRRD.2013.02.0049.PMID: 25144168]
155
ADHD[footnoteRef:13]231ADHDADHDADHD 2631 [13: High prevalence of self-reported photophobia in adult ADHD. Kooij JJ, Bijlenga D. Front Neurol. 2014 Dec 10;5:256. doi: 10.3389/fneur.2014.00256. eCollection 2014.PMID: 25540636]
ADHD69ADHD280.001ADHDADHD 0.05773%ADHD12.3ADHD1.20.0012.31.20.0013.10.0011.40.70.0010.001
4051.05
ADHD 6.0695CI of OR,3.50-10.50SE0.280.0016.181.94-19.64,0.590.0021.581.00-2.51,0.240.052
ADHD
ADHD
3)
5)


[footnoteRef:14]Judd[footnoteRef:15]316:772296229794+ 104+82 62123+636298+766277+564382+5244 [14: Diagnosis, pathophysiology, and treatment of photophobia. Katz BJ, Digre KB. Surv Ophthalmol. 2016 Jul-Aug;61(4):466-77. doi: 10.1016/j.survophthal.2016.02.001. Epub 2016 Feb 12.] [15: Shedding Light on Blepharospasm: A Patient–Researcher Partnership Approach to Assessment of Photophobia and Impact on Activities of Daily Living Rebecca A. Judd , MD,Kathleen B. Digre , MD,Judith EA Warner , MD,Susan F. Schulman , CCRA &Bradley J. Katz , MD, PhD Neuro-Ophthalmology 31(3):49-54 · July 2009.doi.org/10.1080/01658100701247646 ]
157
29794%
13552%
10440%
218%
22584%
25593%
14969%

111630481266[footnoteRef:16]1 [16: Blepharospasm in Japan: A Clinical Observational Study From a Large Referral Hospital in Tokyo. Wakakura M, Yamagami A, Iwasa M. Neuroophthalmology. 2018 Jan 9;42(5):275-283. doi: 10.1080/01658107.2017.1409770. eCollection 2018 Oct.PMID: 30258472]
31
Double single total
195940442210
QOL()16
Katz 14



--18FDG-CT[footnoteRef:17] [17: Photophobia in essential blepharospasm--a positron emission tomographic study. Emoto H, Suzuki Y, Wakakura M, Horie C, Kiyosawa M, Mochizuki M, Kawasaki K, Oda K, Ishiwata K, Ishii K. Mov Disord. 2010 Mar 15;25(4):433-9. doi: 10.1002/mds.22916.PMID: 20014062]
159
160
0.

kmIT


25030402
340 30PCImpairmentdisability

1 Katz [footnoteRef:19] [19: Major review Diagnosis, pathophysiology, and treatment of photophobia. Bradley J. Katz, MD, PhDa,b, *, Kathleen B. Digre, MDa,b. Survey of Ophthalmology 61:466-477,2016]



()



IFAPPPK18 -
Wolters KluwerHealth27Inc.2015625
Functional Vision ScoreFVS)[footnoteRef:20][footnoteRef:21][footnoteRef:22][footnoteRef:23][footnoteRef:24][footnoteRef:25][footnoteRef:26][footnoteRef:27]15FVSAugust Colenbrander [20: Colenbrander A :The Visual system. in Rondinelli RD (ed): Guides to the Evaluation of Permanent Impairment, 6th ed. American Medical Association (AMA) Publications, Chicago,281- 319, 2008(5th ed: Cochiarelli L, Anderson G, eds.277-304,2001)] [21: Colenbrander A: the functional vision score :A coordinated scoring system for visual impairments, disabilities, and handicaps. In Kooiman AC, Looijestijn PL, et al (Eds) Low Vision: Research and New Developments in Rehabilitation Studies in Health Technology and Informatics. IOS Press, Amsterdam, 552-561, 1994] [22: 1 American Medical Association AMA. 82:2 165-167, 2011 FVS 27] [23: 2 Quality of Life(QOL) Functional Vision ScoreFVS. 82:4 463-467, 2011] [24: 3 Visual Acuity ScoreVAS Visual Field ScoreVFS. 82:6 755- 758] [25: 4 WHO FVS Whole Person Impairment(WPI: 82:8 1069-1072 22) 5 Functional Field Score(FFS) 82:10 1339- 1341] [26: 6 82:12 1617- 1619 ] [27: FL-41 Tint Improves Blink Frequency, Light Sensitivity, and Functional Limitations in Patients with Benign Essential Blepharospasm Marcus K.BlackburnMD Randy D.LambMD Kathleen B.DigreMD A. GordonSmithMD Judith E.A.WarnerMD Robert W.McClaneMS Sanjeev D.NandedkarPhD Wendy J.LangebergMPH RichardHolubkovPhD Bradley J.KatzMD, PhD Ophthalmology Volume 116, Issue 5, May 2009, Pages 997-1001]
3
163
VSI 07 827 2847 4867 6887 88100
FVS 10093 9273 7253 5233 3213 120
AMA class 0 1 2 3a 3b 4
WHO Low Vision
Blind ()
3526
26
3 GP:

  
CVI.
2 3/600.056/600.1
3 6/600.16/180.33
23

169
ECLO
20198University of DundeeECLONina Ruth
28020-241
ECLOECLORNIB
side view

CVI
ECLO
CVIRoyal College of Ophthalmologists ()18ECLO
email,182226EASY-READ,CD, Email
rehabilitation officer specific for vision conditionROVY 5224
171
10
Q6. ECLO
LED
Q7.
35/ 67.25269113336000 https://www.gov.uk/carers-allowance
Q9.

172
CVIRoyal College of Ophthalmologists ()18ECLO(part3)
CVI
101
CVIrehabilitation officer specific for vision conditionVision ImpairmentROVI5224
ROVI(2) OT,
ROVI
:



/
2019DundeeNinewellsECLO
174


//
10
1.
2.
  
  


e.
g.
0

Katz [footnoteRef:29] [29: Diagnosis, pathophysiology, and treatment of photophobia. Katz BJ, Digre KB. Surv Ophthalmol. 2016 Jul-Aug;61(4):466-77. doi: 10.1016/j.survophthal.2016.02.001. Epub 2016 Feb 12.]
15
FM(CM)(CTTH)[footnoteRef:30] [30: Fibromyalgia Among Patients With Chronic Migraine and Chronic Tension-Type Headache: A Multicenter Prospective Cross-Sectional Study. Cho SJ, Sohn JH, Bae JS, Chu MK. Headache. 2017 Nov;57(10):1583-1592. doi: 10.1111/head.13191. Epub 2017 Sep 22.PMID: 28940352]
(central sensitization)[footnoteRef:31])CA[footnoteRef:32] [31: Central sensitization in photophobic and non-photophobic migraineurs: possible role of retino nuclear way in the central sensitization process. Lovati C, Mariotti C, Giani L, D'Amico D, Sinelli A, De Angeli F, Capiluppi E, Bussone G, Mariani C. Neurol Sci. 2013 May;34 Suppl 1:S133-5. doi: 10.1007/s10072-013-1369-x.PMID: 23695062] [32: A touchy subject: an assessment of cutaneous allodynia in a chronic migraine population. Mathew PG, Cutrer FM, Garza I. J Pain Res. 2016 Feb 24;9:101-4. doi: 10.2147/JPR.S103238. eCollection 2016.PMID: 2695]
179
180
480nm680nm34
(J Opt Soc Am A Opt Image Sci Vis. 2003 Oct;20(10):1852-8. doi: 10.1364/josaa.20.001852.
fMRIpain modulation system
somatostatin
calcium gene-related peptide receptor (CGRP)
Proton Magnetic Resonance Spectroscopy (1H-MRS) Korean J Intern Med. 2016 Nov; 31(6): 1171–1177.
This study compared rs-fc of affective pain-processing regions in CM with controls. Twelve minutes of resting-state blood oxygenation level-dependent data were collected from 20 interictal adult CM and 20 controls. Resting-state functional connectivity (rs-fc) between 5 affective regions (anterior cingulate cortex, right/left anterior insula, and right/left amygdala) Headache. 2013 May;53(5):737-51. doi: 10.1111/head.12081. Epub 2013 Apr 1.
.
Surv Ophthalmol. 2016 Jul-Aug;61(4):466-77.








182

Photo oculodynia

480nm
MRI
184
0.2-0.8 ipRGC


185
Blue and Red Light-Evoked Pupil Responses in Photophobic Subjects with TBI.
Phillip T. et al.
Optom Vis Sci 2017;94:108-117
TBIipRGCTBI2443.3; 581242.6; 58.10470nm1×1013phots// cm2625nm7×1013 phots // cm2flashing0.1Hzl30ipRGC 2
ipRGC ipRGCTBI ipRGC Optom Vis Sci 2017; 94108Y117
ipRGCTBICNSipRGCTBICNSipRGCipRGCTBIipRGCipRGCTBICNS1ipRGCTBIipRGC
187
188


189
a touchy subject: an assessment of cutaneous allodynia in a chronic migraine population
Mathew PG, Cutrer FM, Garza I.
J Pain Res. 2016 Feb 24;9:101-4. doi: 10.2147/JPR.S103238. eCollection 2016.PMID: 2695
CA CA CAquantitative sensory testing (QST)CAn = 44CA CA90 CA
CA3ICHD-IIICA CA2,3311,62470CA CA CA93±3026160CA 12 CA
ICHD-III12112
190
Subjectsn=44
CA
Central sensitization in photophobic and non-photophobic migraineurs: possible role of retino nuclear way in the central sensitization process
Lovati C, Mariotti C, Giani L, D'Amico D, Sinelli A, De Angeli F, Capiluppi E, Bussone G, Mariani C.
Neurol Sci. 2013 May;34 Suppl 1:S133-5. doi: 10.1007/s10072-013-1369-x.PMID: 23695062
456L. 38.2±13.265391ICHD-II126330248CM62.751.2;p = 0.035385CM84.184.5; p = NS 216169713239 2p = 0.08CM126106713520812
2
193
Photophobia in primary headaches, in essential blepharospasm and in major depression.
Anagnostou E, Vikelis M, Tzavellas E, Ghika A, Kouzi I, Evdokimidis I, Kararizou E.
Int J Neurosci. 2017 Aug;127(8):673-679.
doi: 10.1080/00207454.2016.1231185. Epub 2016 Sep 13.PMID: 27580344

MHCHTHBSMD081006MH27CH21TH20BS18MD206.63TH2.10MHBSCHMDTH

194
195
Fibromyalgia Among Patients With Chronic Migraine and Chronic Tension-Type Headache: A Multicenter Prospective Cross-Sectional Study
Cho SJ, Sohn JH, Bae JS, Chu MK.
Headache. 2017 Nov;57(10):1583-1592. doi: 10.1111/head.13191. Epub 2017 Sep 22.PMID: 28940352




196

—136CM35CTTH4 44.96±12.214584.8 CMCTTH98.5vs 80.0P <.00177.2vs 51.4P5.002CM136158.8 MOH11.8vs 8.6P5.592RLS31.6vs 22.9P5.312CMCTTH
—16898.2119183.076.075.462.4WPI7.7±4.8
CMCTTHWPISSFM-WPICTTHCM8.664.74.062.6P <.001 CTTHCM
197




3.4.2

()
199



200




A.1.2




202






205

DVDCD



206





(2)
208
3..



210
4.
4..
4.1.1

Web EBIS303











LED








213
()×
(1)(2)
()PC



ADL
Web





23




2


Web







221






30



222



Functional Vision Score(FVS)15
0.530
Certificate of Visual Impairment(CVI)CVI

2480nm680nm

223



p1511
224